Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Isoform 4/ATF-A0 acts as a dominant repressor of the E- selectin/NF-ELAM1/delta-A promoter. Additionally we are shipping AFT7 Kits (14) and AFT7 Proteins (8) and many more products for this protein.
Showing 10 out of 62 products:
Dog (Canine) Polyclonal AFT7 Primary Antibody for WB - ABIN2780809
Peters, Liang, Li, Kannan, Peng, Taub, Diamond: ATF-7, a novel bZIP protein, interacts with the PRL-1 protein-tyrosine phosphatase. in The Journal of biological chemistry 2001
Human Polyclonal AFT7 Primary Antibody for FACS, IF - ABIN1881079
Hamard, Dalbies-Tran, Hauss, Davidson, Kedinger, Chatton: A functional interaction between ATF7 and TAF12 that is modulated by TAF4. in Oncogene 2005
Human Polyclonal AFT7 Primary Antibody for ELISA, WB - ABIN1533636
Olsen, Blagoev, Gnad, Macek, Kumar, Mortensen, Mann: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. in Cell 2006
identified two zebrafish orthologs of human ATF7 gene: atf7a and atf7b
CARMA1 (show CARD11 Antibodies)- and MyD88 (show MYD88 Antibodies)-dependent activation of Jun (show JUN Antibodies)/ATF-type AP-1 (show FOSB Antibodies) complexes is a hallmark of ABC (show ABCB6 Antibodies) diffuse large B-cell lymphomas.
mitotic stabilized ATF7 protein re-localizes onto chromatin at the end of telophase and contributes to induce the cyclin D1 (show CCND1 Antibodies) gene expression.
It is negatively related between ATF7 expression and pathological stage and positive correlation with OS and PFS in CRC (show CALR Antibodies). ATF7 expression is a favorable factor for survival of patients with CRC (show CALR Antibodies).
These results suggest that the Cdk1 (show CDK1 Antibodies)-mediated phosphorylation of ATF7 facilitates G2/M progression, at least in part, by enabling Aurora (show AURKA Antibodies) signaling.
ATF7 interacts with TAF12 (show TAF12 Antibodies) and contributes to the hypersensitivity of OCL (show OCLN Antibodies) precursors to 1,25-(OH)D in PD.
Data show that ATF7-4 is an important cytoplasmic negative regulator of ATF7 and ATF2 (show ATF2 Antibodies) transcription factors.
The authors characterized the multisite phosphorylation of the ATF7 activation domain and identified one of the involved kinase, p38beta2 (show MAPK11 Antibodies) mitogen-activated protein kinase (show MAPK1 Antibodies).
ATF7 (show ATF5 Antibodies) interacts with TAF12 (show TAF12 Antibodies) and contributes to the hypersensitivity of OCL (show OCLN Antibodies) precursors to 1,25-(OH)D in PD.
Atf-7-deficient mice exhibit abnormal behaviours and increased 5-HT receptor (show HTR7 Antibodies) 5B (Htr5b) mRNA levels in the dorsal raphe nuclei.
Isoform 4/ATF-A0 acts as a dominant repressor of the E- selectin/NF-ELAM1/delta-A promoter. Isoform 5/ATF-4 acts as a negative regulator, inhibiting both ATF2 and ATF7 transcriptional activities. It may exert these effects by sequestrating in the cytoplasm the Thr-53 phosphorylating kinase, preventing activation. Plays important functions in early cell signaling. Binds 3'), a sequence present in many viral and cellular promoters. Activator of the NF-ELAM1/delta-A site of the E-selectin promoter. Has no intrinsic transcriptional activity, but activates transcription on formation of JUN or FOS heterodimers. Also can bind TRE promoter sequences when heterodimerized with members of the JUN family.
activating transcription factor 7
, cyclic AMP-dependent transcription factor ATF-7-like
, cyclic AMP-dependent transcription factor ATF-7
, transcription factor ATF-A
, cAMP-dependent transcription factor ATF-7